Retinoic Acid and -Galactosylceramide Differentially Regulate B Cell Activation in Vitro and Augment Antibody Production in Vivo

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00004-11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Vitamin a and Retinoic Acid in the Regulation of B-Cell Development and Antibody Production

Vitamins & Hormones
2011English

N-3 PUFA Improves Fatty Acid Composition, Prevents Palmitate-Induced Apoptosis, and Differentially Modifies B Cell Cytokine Secretion in Vitro and Ex Vivo

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2010English

Vitamin a Supplementation and Retinoic Acid Treatment in the Regulation of Antibody Responses in Vivo

Vitamins & Hormones
2007English

B Cell Activation in Specific Polysaccharide Antibody Deficiency

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Intrathecal B-Cell Activation in LGI1 Antibody Encephalitis

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2020English

In Vitro and in Vivo Activation Induces BAFF and APRIL Expression in B Cells

Journal of Immunology
AllergyImmunology
2007English

Chronic Airway Inflammation Provides a Unique Environment for B Cell Activation and Antibody Production

Clinical and Experimental Allergy
AllergyImmunology
2017English

Haploinsufficiency of Activation-Induced Deaminase for Antibody Diversification and Chromosome Translocations Both in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2008English

JNK Isoforms Differentially Regulate Neurite Growth and Regeneration in Dopaminergic Neurons in Vitro

Journal of Molecular Neuroscience
MedicineMolecular NeuroscienceCellular
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy